Abstract
The visual acuity benefits of verteporfin therapy for AMD patients with predominantly classic CNV subfoveal lesions are safely sustained for 2 years, providing more compelling evidence to use verteporfin therapy for these cases. For AMD patients with subfoveal lesions that are minimally classic, there is insufficient evidence to warrant routine use of verteporfin therapy.
Keywords
VerteporfinChoroidal neovascularizationMacular degenerationMedicineOphthalmologyVisual acuityFluorescein angiographySurgery
Related Publications
Photodynamic therapy for circumscribed choroidal haemangioma
ABSTRACT. Purpose: To assess the efficacy of photodynamic therapy (PDT) as a new treatment for circumscribed choroidal haemangioma (CCH). Methods: Eight patients with CCH were t...
Construction and Delivery of Tissue-Engineered Human Retinal Pigment Epithelial Cell Sheets, Using Magnetite Nanoparticles and Magnetic Force
Choroidal neovascularization (CNV) is the most severe form of age-related macular degeneration (AMD), which causes rapid visual loss. Transplantation of cultured retinal pigment...
Age-related macular degeneration
Age-related macular degeneration is a leading cause of visual impairment and severe vision loss. Clinically, it is classified as early-stage (medium-sized drusen and retinal pig...
Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study
Many causes of vision impairment can be prevented or treated. With an ageing global population, the demands for eye health services are increasing. We estimated the prevalence a...
Publication Info
- Year
- 1999
- Type
- article
- Volume
- 117
- Issue
- 10
- Pages
- 1329-1329
- Citations
- 2181
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
2181
OpenAlex
2
Influential
1277
CrossRef
Cite This
Neil M. Bressler
(1999).
Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin.
Archives of Ophthalmology
, 117
(10)
, 1329-1329.
https://doi.org/10.1001/archopht.117.10.1329
Identifiers
- DOI
- 10.1001/archopht.117.10.1329